Enhancing the QUAlity and Transparency Of health Research
(year of development in brackets)
Preferred Reporting Items for Systematic reviews and Meta-Analysis – Protocols for Children (PRISMA-PC) (registered 6 November 2014)
An official extension of the PRISMA-P Statement defining standard protocol items for systematic review in children is currently under development. A Delphi process to generate possible reporting standards for PRISMA-PC and a consensus meeting have taken place in 2015. The evidence synthesis, Delphi survey and international consensus have been completed. The checklists have been finalized (available on request).
Preferred Reporting Items for Systematic reviews and Meta-Analysis – Reporting for Children (PRISMA-C) (registered 6 November 2014)
An official extension of the PRISMA 2009 Statement defining standard reporting items for systematic review in children is currently under development. A Delphi process to generate possible reporting standards for PRISMA-C and a consensus meeting have taken place in 2015. The evidence synthesis, Delphi survey and international consensus have been completed. The checklists have been finalized (available on request). PRISMA-C Statement and Explanation and Elaboration document are expected to be published Q3 2019.
PRISMA-RR: an extension to PRISMA for rapid reviews (registered 4 November 2015)
This reporting guideline will address reporting for rapid reviews, including those with analogous terminology (e.g., rapid evidence synthesis, rapid knowledge synthesis).
Preferred Reporting Items for Systematic Review and Meta-Analyses of traditional Chinese medicine: the PRISMA-TCM Statement (registered 18 August 2016)
The objective is to develop and implement a guideline for reporting systematic reviews and meta-analyses in TCM, as a stand-alone extension to the PRISMA. The guideline contains 1) PRISMA for Chinese herb medicine, and 2) PRISMA for moxibustion.
PRISMA-Search: guidelines for reporting systematic review literature searches (registered 17 February 2016)
Preferred Reporting Items for Overviews of Reviews (PRIOR) (registered 4 January 2017)
This guideline will address the reporting of overviews of reviews. Overviews are increasingly popular knowledge synthesis products that compile data from multiple systematic reviews to provide a single synthesis of relevant evidence for decision-making. We intend to focus the guideline on reporting overviews of healthcare interventions.
An official update of the PRISMA 2009 statement defining standard reporting items for systematic reviews and meta-analyses is currently under development. We will conduct a review of the literature to identify items that could be modified, added, or removed from the PRISMA 2009 checklist. We will then complete a Delphi survey among a panel of journal editors, systematic reviewers, methodologists and end users (e.g. policy makers, guideline developers, patients), to assess the appropriateness of potential items to include in the updated PRISMA checklist. We will also invite the panel to nominate other items for consideration. During an in-person consensus meeting in late 2018, the PRISMA update group will finalize a core set of items to be included in the updated PRISMA checklist. We plan to submit a paper presenting the updated PRISMA checklist, and a revised explanation and elaboration document, to an open-access journal. We will also develop a comprehensive knowledge translation strategy to help journals endorse and implement the guideline.
PRISMA-Ethics: an extension to PRISMA for SRs on ethics literature (registered in 4 October 2018)
This PRISMA extension will take into account the characteristics of systematic reviews (SRs) on literature about ethically sensitive topics. The methods for search and selection will be very close to those applied in “traditional”, i.e. quantitative SRs, using empirical literature. But as SRs on ethically sensitive topics primarily involve conceptual and qualitative analyses and syntheses, these particularities need to be reflected in a reporting guideline (a more comprehensive definition of the scope/the type of literature will be given in the upcoming publication). For the extension of PRIMSA, the PRISMA as well as the ENTREQ statement for qualitative research are used as a basis. The group plans to publish the reporting guideline as an open access paper in the Summer of 2019.
In a constituting session, the executive group agreed on the following steps:
This reporting guideline is an extension to the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA), specifically for systematic reviews research performed in preclinical, in vivo animal models. The guideline development will occur in five phases: 1) Group establishment to help and provide expertise in the guideline development; 2) A cross-sectional study to describe the characteristics of and assess the reporting of contemporary preclinical systematic reviews; 3) Delphi Exercise; 4) Written Guidance; and 5) Dissemination.
The Core Group (n=14 to date) will lead the development and dissemination of the guidelines, and includes members with expertise in various disciplines pertinent to guideline development, systematic reviews and meta-analysis, and in vivo animal experiments. This group formed in Fall 2018, and finalized its membership in February 2020. The group have performed an environmental scan by systematically searching the literature for published preclinical systematic reviews and have identified and synthesized the characteristics of these reviews in Summer 2019. The Delphi will start in Summer 2020 and finish in Fall 2020. The group aim to finalize the guidelines and have the results of the environmental scan and conference proceedings submitted for publication by Winter 2021.
Page last updated on 12 March 2020
|Clinical practice guidelines||AGREE||RIGHT|
|Animal pre-clinical studies||ARRIVE|
|Quality improvement studies||SQUIRE|